OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blockade of CD73 delays glioblastoma growth by modulating the immune environment
Juliana H. Azambuja, Roselena Silvestri Schuh, Luana Roberta Michels, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 9, pp. 1801-1812
Open Access | Times Cited: 47

Showing 26-50 of 47 citing articles:

Enhancing hepatocellular carcinoma management: prognostic value of integrated CCL17, CCR4, CD73, and HHLA2 expression analysis
Wei Gan, Bao‐Ye Sun, Zhangfu Yang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 2

Extracellular adenosine oppositely regulates the purinome machinery in glioblastoma and mesenchymal stem cells
Deborah Pietrobono, Lara Russo, Maria Sofia Bertilacchi, et al.
IUBMB Life (2024) Vol. 76, Iss. 12, pp. 1234-1251
Open Access | Times Cited: 2

Silencing tumor-intrinsic CD73 enhances the chemosensitivity of NSCLC and potentiates the anti-tumoral effects of cisplatin: An in vitro study
Elham Baghbani, Saeed Noorolyai, Shima Rahmani, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112370-112370
Open Access | Times Cited: 13

Interactions between microglia and glioma in tumor microenvironment
Jincheng Tao, Yu Dong, Wei Shao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5

Distinct Polarization Dynamics of Microglia and Infiltrating Macrophages: A Novel Mechanism of Spinal Cord Ischemia/Reperfusion Injury
Hui Li, Pengfei Wang, Lin Tang, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 5227-5239
Open Access | Times Cited: 11

Combination of tumor antigen drainage and immune activation to promote a cancer-immunity cycle against glioblastoma
Xu Han, Xiaomei Zhao, Jincai Luo
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1

Development of a hydrogel-based three-dimensional (3D) glioblastoma cell lines culture as a model system for CD73 inhibitor response study
Marjan Bahraminasab, Samira Asgharzade, Ali Doostmohamadi, et al.
BioMedical Engineering OnLine (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Strategies to Enhance the Efficacy of T-Cell Therapy for Central Nervous System Tumors
Deepak Upreti, David Bakhshinyan, Darin Bloemberg, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 11

Generation of a Retargeted Oncolytic Herpes Virus Encoding Adenosine Deaminase for Tumor Adenosine Clearance
Chiara Gentile, Arianna Finizio, Guendalina Froechlich, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13521-13521
Open Access | Times Cited: 10

Adenosine Inhibits Cell Proliferation Differently in Human Astrocytes and in Glioblastoma Cell Lines
Helena Marcelino, Tiago M. A. Carvalho, Joana Tomás, et al.
Neuroscience (2021) Vol. 467, pp. 122-133
Closed Access | Times Cited: 9

Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?
Abdul‐rizaq Hamoud, Karen Bach, Ojal Kakrecha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11835-11835
Open Access | Times Cited: 6

The tumour ecology of quiescence: Niches across scales of complexity
Simón P. Castillo, Felipe Gálvez‐Cancino, Jiali Liu, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 139-149
Open Access | Times Cited: 3

An overview of current therapeutic strategies for glioblastoma and the role of CD73 as an alternative curative approach
Samaneh Arab, Farkhonde Hasannejad
Clinical & Translational Oncology (2021) Vol. 24, Iss. 5, pp. 742-756
Closed Access | Times Cited: 6

Pharmacological and genetic strategies for targeting adenosine to enhance adoptive T cell therapy of cancer
Kevin Sek, Lev M. Kats, Phillip K. Darcy, et al.
Current Opinion in Pharmacology (2020) Vol. 53, pp. 91-97
Closed Access | Times Cited: 5

Targeting CD73 for anti-tumor immunity
Shi Liu, Pierre-Antoine Laurent, Éric Deutsch, et al.
Elsevier eBooks (2024)
Closed Access

Emerging immune-based technologies for high-grade gliomas
Alice Giotta Lucifero, Sabino Luzzi
Expert Review of Anticancer Therapy (2022) Vol. 22, Iss. 9, pp. 957-980
Closed Access | Times Cited: 2

Infiltrating circulating monocytes provide an important source of BMP4 at the early stage of spinal cord injury
Weiyun Shen, Shuxin Liu, Xiaojing Wei, et al.
Disease Models & Mechanisms (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 2

Development of a hydrogel-based three Dimensional (3D) Glioblastoma Cell lines Culture as a Model System for CD73 inhibitor response study
Marjan Bahraminasab, Samira Asgharzade, Ali Doostmohamadi, et al.
Research Square (Research Square) (2023)
Open Access

Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling
Davide Ferrari, Stefania Gessi, Stefania Merighi, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access

Glioblastoma - actual knowledge and future perspectives
Dominik Bilicki, Mikołaj Zbrożek, Marta Fudalej, et al.
Oncoreview (2022) Vol. 12, Iss. 2(46), pp. 35-44
Open Access

Previous Page - Page 2

Scroll to top